Published in Curr Opin Immunol on February 01, 1996
An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A (1999) 3.15
CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med (1997) 2.51
B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66
CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J Exp Med (2001) 1.61
Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med (1998) 1.47
CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys J (2005) 1.38
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci (2006) 1.31
Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells. Proc Natl Acad Sci U S A (2002) 1.22
Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding. Protein Sci (1999) 1.14
Genetic engineering of T cells for adoptive immunotherapy. Immunol Res (2008) 1.05
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors. J Exp Med (1997) 0.91
Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition. J Exp Med (1997) 0.83
T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med (2000) 4.16
Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity (1998) 4.15
Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol (1988) 1.86
Binding of a soluble alpha beta T-cell receptor to superantigen/major histocompatibility complex ligands. Proc Natl Acad Sci U S A (1994) 1.10
C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. J Immunol (1988) 1.09
Complexes of N antitermination protein of phage lambda with specific and nonspecific RNA target sites on the nascent transcript. Biochemistry (1997) 1.05
A novel Creb family gene telomeric of HLA-DRA in the HLA complex. Genomics (1995) 1.02
Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein. Infect Immun (1990) 0.99
Specificity mechanisms in the control of transcription. Biophys Chem (1996) 0.99
Inhibition of immune precipitation by complement. J Immunol (1984) 0.99
Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. Proc Natl Acad Sci U S A (1997) 0.95
Covalent association of C3b with C4b within C5 convertase of the classical complement pathway. J Exp Med (1987) 0.91
Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J Immunol (1998) 0.91
Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. J Biol Chem (1990) 0.90
Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings. J Vet Pharmacol Ther (1998) 0.87
Mepivacaine: its pharmacological effects and their relationship to analytical findings in the horse. J Vet Pharmacol Ther (1999) 0.86
Pharmacology of AMG 181, a human anti-α4 β7 antibody that specifically alters trafficking of gut-homing T cells. Br J Pharmacol (2013) 0.85
Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition. J Exp Med (1997) 0.83
Murine monoclonal anti-Ba antibody that enhances haemolytic activity of factor B. Immunology (1991) 0.80
Preclinical development of AMG 139, a human antibody specifically targeting IL-23. Br J Pharmacol (2014) 0.80
Determination of highest no effect dose (HNED) for local anaesthetic responses to procaine, cocaine, bupivacaine and benzocaine. Equine Vet J (1996) 0.79
Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity. Arterioscler Thromb Vasc Biol (2000) 0.78
Number of hits necessary for complement-mediated hemolysis. Microbiol Immunol (1986) 0.77
Structural and thermodynamic characteristics of the binding of the lambda N protein to a RNA hairpin. Nucleic Acids Symp Ser (1995) 0.77
Bactericidal activity of C9-deficient human serum. J Immunol (1992) 0.77
RNA interactions in the regulation of transcription. Nucleic Acids Symp Ser (1995) 0.75
Treatment of Appendicitis in Children. Br Med J (1911) 0.75
Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies. J Immunol Methods (1987) 0.75